Similar articles

• Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

  Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, et al. Eng C, et al. Hum Mol Genet. 1994 Feb;3(2):237-41. doi: 10.1093/hmg/3.2.237. Hum Mol Genet. 1994. PMID: 7911697
• Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.

  Mulligan LM, Ponder BA. Mulligan LM, et al. J Clin Endocrinol Metab. 1995 Jul;80(7):1989-95. doi: 10.1210/jcem.80.7.7608246. J Clin Endocrinol Metab. 1995. PMID: 7608246 Review. No abstract available.
• [One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].

  Fehmann HC, Göke B. Fehmann HC, et al. Z Gastroenterol. 1994 Jul;32(7):416-7. Z Gastroenterol. 1994. PMID: 7975780 German. No abstract available.
• The physical map of the human RET proto-oncogene.

  Pasini B, Hofstra RM, Yin L, Bocciardi R, Santamaria G, Grootscholten PM, Ceccherini I, Patrone G, Priolo M, Buys CH, et al. Pasini B, et al. Oncogene. 1995 Nov 2;11(9):1737-43. Oncogene. 1995. PMID: 7478601
• [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].

  Hofstra RM, van der Luijt RB, Lips CJ. Hofstra RM, et al. Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.